Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial.
BACKGROUND: Japanese encephalitis virus (JEV), although confined to Asia, causes about 35000-50000 cases and 10000 deaths every year, and is the most important cause of encephalitis worldwide. There is no known antiviral treatment for any flavivirus. Results from in-vitro studies and work in animal...
Hoofdauteurs: | Solomon, T, Dung, N, Wills, B, Kneen, R, Gainsborough, M, Diet, T, Thuy, T, Loan, H, Khanh, VC, Vaughn, D, White, N, Farrar, J |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2003
|
Gelijkaardige items
-
Interferon alpha in the pathogenesis and treatment Japanese encephalitis
door: Solomon, T, et al.
Gepubliceerd in: (2004) -
Poliomyelitis-like illness due to Japanese encephalitis virus.
door: Solomon, T, et al.
Gepubliceerd in: (1998) -
Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis.
door: Solomon, T, et al.
Gepubliceerd in: (2002) -
Proinflammatory cytokines and chemokines in humans with Japanese encephalitis.
door: Winter, P, et al.
Gepubliceerd in: (2004) -
An evaluation of the usefulness of neuroimaging for the diagnosis of Japanese encephalitis.
door: Dung, N, et al.
Gepubliceerd in: (2009)